Terms: = Leukemia AND FIP1L1, DKFZp586K0717, 81608, ENSG00000145216, Q6UN15 AND Treatment
93 results:
1. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
[TBL] [Abstract] [Full Text] [Related]
2. Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic leukemia/Lymphoblastic Lymphoma.
Paolino J; Dimitrov B; Apsel Winger B; Sandoval-Perez A; Rangarajan AV; Ocasio-Martinez N; Tsai HK; Li Y; Robichaud AL; Khalid D; Hatton C; Gillani R; Polonen P; Dilig A; Gotti G; Kavanagh J; Adhav AA; Gow S; Tsai J; Li Y; Ebert BL; Van Allen EM; Bledsoe J; Kim AS; Tasian SK; Cooper SL; Cooper TM; Hijiya N; Sulis ML; Shukla NN; Magee JA; Mullighan CG; Burke MJ; Luskin MR; Mar BG; Jacobson MP; Harris MH; Stegmaier K; Place AE; Pikman Y
Clin Cancer Res; 2023 Nov; 29(22):4613-4626. PubMed ID: 37725576
[TBL] [Abstract] [Full Text] [Related]
3. fip1l1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case report.
Ali S; Al-Qattan Y; Awny W; Hamadah A; Pinto K; AlShemmari S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1769. PubMed ID: 36517458
[TBL] [Abstract] [Full Text] [Related]
4. Two pediatric oncologic cases of hypereosinophilic syndrome and review of the literature.
Voeller J; DeNapoli T; Griffin TC
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1710. PubMed ID: 36241191
[TBL] [Abstract] [Full Text] [Related]
5. [Emergence of mutation in the colony-stimulating factor 3 receptor gene during follow-up of unclassifiable myeloproliferative neoplasm].
Harada S; Okada K; Yokoyama S; Hidaka D; Hayase E; Onozawa M; Goto H; Hashimoto D; Kahata K; Endo T; Teshima T
Rinsho Ketsueki; 2021; 62(11):1609-1614. PubMed ID: 34866084
[TBL] [Abstract] [Full Text] [Related]
6. Successful treatment and integrated genomic analysis of an infant with fip1l1-RARA fusion-associated myeloid neoplasm.
Miltiadous O; Petrova-Drus K; Kaicker S; Mathew S; Kluk M; Geyer JT; Rodriguez-Sanchez I; Bouvier N; Inghirami G; Stieglitz E; Khedoudja N; Benayed R; Richardson M; Anderson W; Benhamida J; You D; Londono D; Kung AL; Prockop SE; Roshal M; Zhang Y; Shukla N
Blood Adv; 2022 Feb; 6(4):1137-1142. PubMed ID: 34551074
[TBL] [Abstract] [Full Text] [Related]
7. fip1l1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction.
Tennenbaum J; Groh M; Venditti L; Campos-Gazeau F; Chalayer E; De Broucker T; Hamidou M; Hunault M; Lyoubi A; Meunier R; Muron T; Sène D; Slama B; Guidoux C; Lefèvre G; Kahn JE; Denier C; Rohmer J
Stroke; 2021 Oct; 52(10):e605-e609. PubMed ID: 34304603
[TBL] [Abstract] [Full Text] [Related]
8. Venous thrombosis and predictors of relapse in eosinophil-related diseases.
Réau V; Vallée A; Terrier B; Plessier A; Abisror N; Ackermann F; Benainous R; Bohelay G; Chabi-Charvillat ML; Cornec D; Desbois AC; Faguer S; Freymond N; Gaillet A; Hamidou M; Killian M; Le Jeune S; Marchetti A; Meyer G; Osorio-Perez F; Panel K; Rautou PE; Rohmer J; Simon N; Tcherakian C; Vasse M; Zuelgaray E; Lefevre G; Kahn JE; Groh M
Sci Rep; 2021 Mar; 11(1):6388. PubMed ID: 33737704
[TBL] [Abstract] [Full Text] [Related]
9. [Hypereosinophilic syndromes].
Groh M; Lefèvre G; Ackermann F; Étienne N; Kahn JE
Rev Prat; 2019 Sep; 69(7):767-773. PubMed ID: 32233322
[TBL] [Abstract] [Full Text] [Related]
10. The Efficacy of Imatinib Mesylate in the treatment of a Rare Lytic Bone Lesion Caused by Hypereosinophilic Syndrome/Chronic Eosinophilic leukemia: A Case Report.
Nomura H; Iwato K; Fujiwara M; Takano Y; Arima J
JBJS Case Connect; 2020; 10(1):e0126. PubMed ID: 32224679
[TBL] [Abstract] [Full Text] [Related]
11. treatment-free remission in fip1l1-PDGFRA-positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation.
Metzgeroth G; Schwaab J; Naumann N; Jawhar M; Haferlach T; Fabarius A; Hochhaus A; Hofmann WK; Cross NCP; Reiter A
Blood Adv; 2020 Feb; 4(3):440-443. PubMed ID: 31995156
[TBL] [Abstract] [Full Text] [Related]
12. A complex and cryptic intrachromosomal rearrangement generating the fip1l1_PDGFRA in adult acute myeloid leukemia.
Coccaro N; Anelli L; Orsini P; Zagaria A; Minervini A; Impera L; Tota G; Minervini CF; Cumbo C; Parciante E; Coserva MR; Attolico I; Specchia G; Albano F
Cancer Genet; 2019 Nov; 239():8-12. PubMed ID: 31450116
[TBL] [Abstract] [Full Text] [Related]
13. Atypical Phenotype and treatment Response Pattern in a Patient with fip1l1-PDGFRα Mutation.
Bikhchandani M; Johnson R; Tuan B; Tefferi A
Acta Haematol; 2018; 140(2):67-70. PubMed ID: 30184522
[TBL] [Abstract] [Full Text] [Related]
14. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract] [Full Text] [Related]
15. EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients.
Zhang L; Liu Y; Wang M; Wu Z; Li N; Zhang J; Yang C
J Mol Cell Biol; 2017 Dec; 9(6):477-488. PubMed ID: 29272522
[TBL] [Abstract] [Full Text] [Related]
16. A neoplasm with fip1l1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia.
Oberley MJ; Denton C; Ji J; Hiemenz M; Bhojwani D; Ostrow D; Wu S; Gaynon P; Raca G
Cancer Genet; 2017 Oct; 216-217():91-99. PubMed ID: 29025601
[TBL] [Abstract] [Full Text] [Related]
17. Leukemogenic kinase fip1l1-PDGFRA and a small ubiquitin-like modifier E3 ligase, PIAS1, form a positive cross-talk through their enzymatic activities.
Ibata M; Iwasaki J; Fujioka Y; Nakagawa K; Darmanin S; Onozawa M; Hashimoto D; Ohba Y; Hatakeyama S; Teshima T; Kondo T
Cancer Sci; 2017 Feb; 108(2):200-207. PubMed ID: 27960034
[TBL] [Abstract] [Full Text] [Related]
18. Severe Prolonged Cough as Presenting Manifestation of fip1l1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association.
Roufosse F; Heimann P; Lambert F; Sidon P; Bron D; Cottin V; Cordier JF
Respiration; 2016; 91(5):374-9. PubMed ID: 27164940
[TBL] [Abstract] [Full Text] [Related]
19. Long-term outcomes of imatinib in patients with fip1l1/ PDGFRA associated chronic eosinophilic leukemia: experience of a single center in China.
Qu SQ; Qin TJ; Xu ZF; Zhang Y; Ai XF; Li B; Zhang HL; Fang LW; Pan LJ; Hu NB; Xiao ZJ
Oncotarget; 2016 May; 7(22):33229-36. PubMed ID: 27120808
[TBL] [Abstract] [Full Text] [Related]
20. Hypereosinophilic Syndrome.
Curtis C; Ogbogu P
Clin Rev Allergy Immunol; 2016 Apr; 50(2):240-51. PubMed ID: 26475367
[TBL] [Abstract] [Full Text] [Related]
[Next]
